|1.||Du, Jie: 2 articles (10/2014 - 01/2013)|
|2.||Harris, Adrian L: 2 articles (12/2011 - 09/2011)|
|3.||Izadmehr, Sudeh: 1 article (10/2015)|
|4.||Ohlmeyer, Michael: 1 article (10/2015)|
|5.||Kastrinsky, David B: 1 article (10/2015)|
|6.||Narla, Goutham: 1 article (10/2015)|
|7.||Sangodkar, Jaya: 1 article (10/2015)|
|8.||Zaware, Nilesh: 1 article (10/2015)|
|9.||Dhawan, Neil S: 1 article (10/2015)|
|10.||Dong, Yanjun: 1 article (10/2014)|
11/10/2011 - "Among the sulfenamides, the most potent compounds were derived from dibenzazepine 7b and dihydroacridine 8b as determined in all of the four cancer cell lines. "
01/01/2009 - "A series of 11-phenyl-[b,e]-dibenzazepine compounds were synthesized and shown to be inhibitors of tumor cell proliferation with IC(50) values ranging from submicromolar to micromolar concentrations. "
10/01/2015 - "The phenothiazine and dibenzazepine tricyclics are potent neurotropic drugs with a documented but underutilized anti-cancer side effect. "
09/15/2011 - "However, blockade of Notch signaling by dibenzazepine, a γ-secretase inhibitor, disrupted the large vessels and abolished the tumor resistance. "
12/07/2011 - "The mice were treated with dibenzazepine (DBZ), a γ-secretase inhibitor that blocks all Notch signaling, or a DLL4-specific blocking monoclonal antibody, alone or in combination with ionizing radiation (n = 5-10 mice per group), and response was assessed by tumor growth delay. "
|3.||Cardiac Arrhythmias (Arrythmia)
08/01/1986 - "[Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives]."
08/01/1986 - "[Electrophysiologic research on the anti-arrhythmia properties of bonnecor--a new dibenzazepine derivative]."
05/01/1990 - "The antiarrhythmic activity of 20 derivatives of dibenzazepine (the effects on the maximal effective rabbit heart auricle contraction rate, aconitine-induced arrhythmia in rats under or without anesthesia) was studied. "
05/01/1994 - "The antiarrhythmic properties of the dibenzazepine derivative bonnecor and derivatives of mesidides of alpha-azacycloalkanocarboxylic acids were studied in various experimental arrhythmia models. "
|4.||Peripheral Vascular Diseases (Peripheral Vascular Disease)
|5.||Trigeminal Neuralgia (Tic Douloureux)
|1.||Amyloid Precursor Protein Secretases (beta-Secretase)
|5.||Small Interfering RNA (siRNA)
|8.||Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)